These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

807 related articles for article (PubMed ID: 34846524)

  • 1. Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer.
    Chen D; Chen H; Chi L; Fu M; Wang G; Wu Z; Xu S; Sun C; Xu X; Lin L; Cheng J; Jiang W; Dong X; Lu J; Zheng J; Chen G; Li G; Zhuo S; Yan J
    JAMA Netw Open; 2021 Nov; 4(11):e2136388. PubMed ID: 34846524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathomics Signature for Prognosis and Chemotherapy Benefits in Stage III Colon Cancer.
    Jiang W; Wang H; Dong X; Yu X; Zhao Y; Chen D; Yan B; Cheng J; Zhuo S; Wang H; Yan J
    JAMA Surg; 2024 May; 159(5):519-528. PubMed ID: 38416471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer.
    Jiang Y; Li T; Liang X; Hu Y; Huang L; Liao Z; Zhao L; Han Z; Zhu S; Wang M; Xu Y; Qi X; Liu H; Yang Y; Yu J; Liu W; Cai S; Li G
    JAMA Surg; 2017 Jul; 152(7):e171087. PubMed ID: 28538950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Immune Cell Signature Is Associated With Disease-Free Survival and Adjuvant Chemosensitivity of Patients With Resectable Gastric Cancer.
    Yan H; Chen Y; Yang Z; Li Z; Che X; Xiao J; Liu Y; Qu X
    Front Immunol; 2020; 11():621623. PubMed ID: 33613554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Collagen Signature in the Tumor Microenvironment With Lymph Node Metastasis in Early Gastric Cancer.
    Chen D; Chen G; Jiang W; Fu M; Liu W; Sui J; Xu S; Liu Z; Zheng X; Chi L; Lin D; Li K; Chen W; Zuo N; Lu J; Chen J; Li G; Zhuo S; Yan J
    JAMA Surg; 2019 Mar; 154(3):e185249. PubMed ID: 30698615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach.
    Lin JX; Wang ZK; Hong QQ; Zhang P; Zhang ZZ; He L; Wang Q; Shang L; Wang LJ; Sun YF; Li ZX; Liu JJ; Ding FH; Lin ED; Fu YA; Lin SM; Xie JW; Li P; Zheng CH; Huang CM
    JAMA Netw Open; 2021 Oct; 4(10):e2128217. PubMed ID: 34609494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomarker Support Vector Machine Classifier for Prediction of Gastric Cancer Survival and Adjuvant Chemotherapeutic Benefit.
    Jiang Y; Xie J; Han Z; Liu W; Xi S; Huang L; Huang W; Lin T; Zhao L; Hu Y; Yu J; Zhang Q; Li T; Cai S; Li G
    Clin Cancer Res; 2018 Nov; 24(22):5574-5584. PubMed ID: 30042208
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
    Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
    Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
    Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma.
    He MM; Zhang DS; Wang F; Wang ZQ; Luo HY; Ren C; Jin Y; Chen DL; Xu RH
    World J Gastroenterol; 2014 Jan; 20(1):264-73. PubMed ID: 24415881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Deep Learning CT Signature to Predict Survival and Chemotherapy Benefit in Gastric Cancer: A Multicenter, Retrospective Study.
    Jiang Y; Jin C; Yu H; Wu J; Chen C; Yuan Q; Huang W; Hu Y; Xu Y; Zhou Z; Fisher GA; Li G; Li R
    Ann Surg; 2021 Dec; 274(6):e1153-e1161. PubMed ID: 31913871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment combining cellular immunotherapy with chemotherapy improves the clinical outcome of patients with stage II/III gastric cancer.
    Wang Y; Wang C; Xiao H; Niu C; Wu H; Jin H; Yao C; He H; Tian H; Han F; Li D; Han W; Xu J; Chen J; Cui J; Li W
    Cancer Med; 2017 Jan; 6(1):45-53. PubMed ID: 27790867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term outcomes of laparoscopic gastrectomy for locally advanced gastric cancer with serosa-invasion].
    Li PA; Zhang F; Li ZY; Shi Y; Qian F; Zhao YL; Chen J; Tan CJ; Wang ZW; Wen Y; Yu PW
    Zhonghua Wai Ke Za Zhi; 2024 Aug; 62(8):744-750. PubMed ID: 38937125
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
    Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
    J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer.
    Cao Y; Liu H; Li H; Lin C; Li R; Wu S; Zhang H; He H; Zhang W; Xu J
    JAMA Surg; 2017 Nov; 152(11):e173120. PubMed ID: 28903131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical implications of Naples prognostic scores in patients with resectable Siewert type II-III adenocarcinoma of the esophagogastric junction].
    Jin P; Ma G; Liu Y; Ke B; Liu HM; Liang H; Zhang RP
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jan; 27(1):54-62. PubMed ID: 38262901
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiographical Evaluation of Tumor Immunosuppressive Microenvironment and Treatment Outcomes in Gastric Cancer: A Retrospective, Multicohort Study.
    Lin JX; Lin JP; Weng Y; Lv CB; Chen JH; Zhan CY; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zhou WX; Zhang XJ; Zheng CH; Cai LS; Ma YB; Huang CM
    Ann Surg Oncol; 2022 Aug; 29(8):5022-5033. PubMed ID: 35294651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors and Prognostic Implications of Perioperative Chemotherapy Completion in Gastric Cancer.
    Karagkounis G; Squires MH; Melis M; Poultsides GA; Worhunsky D; Jin LX; Fields RC; Spolverato G; Pawlik TM; Votanopoulos KI; Levine EA; Schmidt C; Bloomston M; Cho CS; Weber S; Masi A; Berman R; Pachter HL; Staley CA; Newman E; Maithel SK; Hatzaras I
    J Gastrointest Surg; 2017 Dec; 21(12):1984-1992. PubMed ID: 28963709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the Collagen Signature in the Tumor Microenvironment With Recurrence and Survival of Patients With T4N0M0 Colon Cancer.
    Chen W; Dong S; Liu X; Wang G; Xu S; Lei S; Zhuo S; Yan J
    Dis Colon Rectum; 2021 May; 64(5):563-575. PubMed ID: 33538520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.